Doubling a dose would expose patients to supratherapeutic plasma concentrations exceeding even the 4.5 mg level, with proportionally higher GI risk and possible dehydration from vomiting or diarrhea
Previous literature has demonstrated that GSH levels are elevated in various tumors, including breast, colon, laryngeal, gastric, and lung cancers [16]
People who have severe symptoms of growth hormone decline that are interfering with their life often do better at first with hGH therapy
It is typically administered through subcutaneous or intramuscular injections
20 Protein concentration was determined using the procedure described by Lowry et al
According to recent data, GLP-1 prescriptions have penetrated beyond specialist prescribing into primary care